Subscribe
Subscription banner for an ophthalmic newsletter
FDA Accepts Oxular’s IND Application for the Treatment of Diabetic Macular Edema

The U.S. Food and Drug Administration has approved Oxular Limited's investigational new drug applica...

read more
FDA Accepts Oxular’s IND Application for the Treatment of Diabetic Macular Edema
January 26, 2023
FDA Approves Genentech’s Vabysmo to Treat Wet AMD and DME

The FDA has approved Genentech's Vabysmo (faricimab-svoa) for the treatment of wet age-related macul...

read more
FDA Approves Genentech’s Vabysmo to Treat Wet AMD and DME
February 02, 2022
More